v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
Total
Common Stock
Additional Paid-in- Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024   101,910,883        
Beginning balance at Dec. 31, 2024 $ 315,179,130 $ 10,191 $ 321,087,583 $ (1,402,167) $ 1,221,869 $ (5,738,346)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock repurchased (in shares)   (1,953,169)        
Common stock repurchased (5,751,954) $ (195) (5,751,759)      
Stock-based compensation (in shares)   391,777        
Stock-based compensation 4,282,366 $ 39 4,282,327      
Shares withheld for taxes (in shares)   (165,603)        
Shares withheld for taxes (1,200,977) $ (17) (1,200,960)      
Net loss attributable to noncontrolling interests (1,673,985)         (1,673,985)
Foreign currency translation 495,538       495,538  
Net loss attributable to stockholders of DocGo Inc. and Subsidiaries (9,405,315)     (9,405,315)    
Ending balance (in shares) at Mar. 31, 2025   100,183,888        
Ending balance at Mar. 31, 2025 301,924,803 $ 10,018 318,417,191 (10,807,482) 1,717,407 (7,412,331)
Beginning balance (in shares) at Dec. 31, 2024   101,910,883        
Beginning balance at Dec. 31, 2024 315,179,130 $ 10,191 321,087,583 (1,402,167) 1,221,869 (5,738,346)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss attributable to noncontrolling interests (3,808,632)          
Net loss attributable to stockholders of DocGo Inc. and Subsidiaries (20,560,561)          
Ending balance (in shares) at Jun. 30, 2025   97,757,075        
Ending balance at Jun. 30, 2025 287,730,732 $ 9,776 316,509,060 (21,962,728) 2,721,602 (9,546,978)
Beginning balance (in shares) at Mar. 31, 2025   100,183,888        
Beginning balance at Mar. 31, 2025 301,924,803 $ 10,018 318,417,191 (10,807,482) 1,717,407 (7,412,331)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock repurchased (in shares)   (2,527,900)        
Common stock repurchased (5,076,952) $ (253) (5,076,699)      
Stock-based compensation (in shares)   166,042        
Stock-based compensation 3,308,154 $ 17 3,308,137      
Shares withheld for taxes (in shares)   (64,955)        
Shares withheld for taxes (139,575) $ (6) (139,569)      
Net loss attributable to noncontrolling interests (2,134,647)         (2,134,647)
Other comprehensive income (loss) 1,004,195       1,004,195  
Net loss attributable to stockholders of DocGo Inc. and Subsidiaries (11,155,246)     (11,155,246)    
Ending balance (in shares) at Jun. 30, 2025   97,757,075        
Ending balance at Jun. 30, 2025 $ 287,730,732 $ 9,776 316,509,060 (21,962,728) 2,721,602 (9,546,978)
Beginning balance (in shares) at Dec. 31, 2025 98,640,059 98,640,059        
Beginning balance at Dec. 31, 2025 $ 125,871,337 $ 9,864 325,416,366 (183,801,795) 2,387,404 (18,140,502)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation (in shares)   173,085        
Stock-based compensation 3,224,784 $ 17 3,224,767      
Shares withheld for taxes (in shares)   (34,731)        
Shares withheld for taxes (22,203) $ (3) (22,200)      
Net loss attributable to noncontrolling interests (1,936,706)         (1,936,706)
Distributions paid to noncontrolling interests (1,024,270)         (1,024,270)
Other comprehensive income (loss) (139,420)       (139,420)  
Net loss attributable to stockholders of DocGo Inc. and Subsidiaries (14,763,131)     (14,763,131)    
Ending balance (in shares) at Mar. 31, 2026   98,778,413        
Ending balance at Mar. 31, 2026 $ 111,210,391 $ 9,878 328,618,933 (198,564,926) 2,247,984 (21,101,478)
Beginning balance (in shares) at Dec. 31, 2025 98,640,059 98,640,059        
Beginning balance at Dec. 31, 2025 $ 125,871,337 $ 9,864 325,416,366 (183,801,795) 2,387,404 (18,140,502)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss attributable to noncontrolling interests (4,108,727)          
Net loss attributable to stockholders of DocGo Inc. and Subsidiaries $ (30,583,408)          
Ending balance (in shares) at Jun. 30, 2026 98,858,369 98,858,369        
Ending balance at Jun. 30, 2026 $ 95,781,059 $ 9,886 331,260,586 (214,385,203) 2,169,289 (23,273,499)
Beginning balance (in shares) at Mar. 31, 2026   98,778,413        
Beginning balance at Mar. 31, 2026 111,210,391 $ 9,878 328,618,933 (198,564,926) 2,247,984 (21,101,478)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation (in shares)   103,484        
Stock-based compensation 2,655,526 $ 10 2,655,516      
Shares withheld for taxes (in shares)   (23,528)        
Shares withheld for taxes (13,865) $ (2) (13,863)      
Net loss attributable to noncontrolling interests (2,172,021)         (2,172,021)
Other comprehensive income (loss) (78,695)       (78,695)  
Net loss attributable to stockholders of DocGo Inc. and Subsidiaries $ (15,820,277)     (15,820,277)    
Ending balance (in shares) at Jun. 30, 2026 98,858,369 98,858,369        
Ending balance at Jun. 30, 2026 $ 95,781,059 $ 9,886 $ 331,260,586 $ (214,385,203) $ 2,169,289 $ (23,273,499)